HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients [Phase 2]
A Phase 2 pilot trial evaluated a regimen of maraviroc plus ritonavir-boosted atazanavir in treatment-naive HIV-1 patients; the study is com…
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin [Phase 3]
Phase 3 trial comparing efavirenz-based versus nevirapine-based antiretroviral therapy in HIV-infected patients receiving rifampin. The stud…
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla [Phase 4]
Phase 4 trial update of HIV-1 infected, antiretroviral-experienced subjects switching to Atripla (efavirenz/emtricitabine/tenofovir disoprox…
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial [Phase 4]
Phase 4 randomized open-label trial evaluating switching HIV-1 patients taking Kivexa plus Kaletra to address cholesterol elevations. The st…
-
FDA approval · 2011-11-18FDA Approved: COMBIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for COMBIVIR (lamivudine and zidovudine) from ViiV Healthcare Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-11-18FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Retrovir (zidovudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2011-11-18FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Emtriva (emtricitabine) submitted by Gilead Sciences, Inc.
-
FDA approval · 2011-11-18FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for RETROVIR (Zidovudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2011-11-18FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company, potentially updating labeling or e…
-
FDA approval · 2011-11-18FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2011-11-18FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approval of a supplemental application for RETROVIR (zidovudine) filed by ViiV Healthcare Company.
-
FDA approval · 2011-11-18FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for ZIAGEN (abacavir sulfate) from ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Appropriate Timing of HAART in Co-infected HIV/TB Patients [Phase 4]
This update covers a Phase 4 trial evaluating the optimal timing of HAART in patients co-infected with HIV and tuberculosis, which was termi…
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks [Phase 2]
Phase 2 trial results indicate the HIV prevention program targeting high-risk social networks is effective in preventing HIV infections.
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Ritonavir-boosted Lopinavir Monotherapy [Phase 3]
Phase 3 trial evaluating ritonavir-boosted lopinavir monotherapy for HIV has completed.
-
CLINICAL_TRIALS research · 2011-11-10Clinical Trial Update: Bioequivalence Study of Pediatric Formulations to Treat HIV Infection [Phase 1]
A Phase 1 bioequivalence study of pediatric formulations for HIV infection is being conducted, with unknown status at the time of reporting.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects [Phase 3]
A Phase 3 study evaluating regimens containing GW433908 (fosamprenavir) in HIV-1 infected subjects has completed, and results were posted in…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis [Phase 3]
A Phase 3 trial conducted by All India Institute of Medical Sciences evaluating thrice-weekly Directly Observed Treatment, Short-Course (DOT…
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Drug Interaction Study Between Dolutegravir and Prednisone [Phase 1]
A Phase 1 study evaluating the interaction between dolutegravir and prednisone has been completed.
-
FDA approval · 2011-11-02FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for ISENTRESS (raltegravir) from Merck Sharp & Dohme LLC, extending or updating its approved use…
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection [Phase 3]
Phase 3 trial update for a fixed-dose combination of saquinavir/ritonavir in treatment-naive HIV-1 infection; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis [Phase 4]
A Phase 4 trial comparing immediate versus deferred initiation of antiretroviral therapy in HIV-infected adults undergoing tuberculosis trea…
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Etravirine Plus 2 Analogs in HIV-infected Patients
A completed clinical trial evaluating etravirine in combination with two analogs in HIV infection.
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens [Phase 4]
Phase 4 trial evaluating the effect of maraviroc on immune responses to novel antigens in HIV-1 infected individuals; the study was terminat…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs) [Phase 4]
Phase 4 clinical trial update examining interactions between antiretrovirals and combined oral contraceptives; the study status is completed…